(Q37364321)

English

Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD)

scientific article published on April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD) (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

0 references

1 reference

based on heuristic

inferred from title

Kathleen Falster

7

0 references

Adeeba Kamarulzaman

3

object named as

Adeeba Kamarulzaman

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

object named as

Jennifer Hoy

4

0 references

Somnuek Sungkanuparph

5

object named as

Somnuek Sungkanuparph

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

author name string

Sam Egger

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Kathy Petoumenos

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

John Chuah

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jialun Zhou

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Matthew G Law

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Asia Pacific HIV Observational Database (APHOD)

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

1 April 2009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Journal of Acquired Immune Deficiency Syndromes

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

50

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

513-520

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

Antiretroviral therapy in a thousand patients with AIDS in Haiti

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

The TREAT Asia HIV Observational Database: baseline and retrospective data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

6 September 2017

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

26 June 2018

Contrasting quantitative alterations in CD4+ and CD8+ lymphocytes in HIV-infected African Americans compared with the Caucasian population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

26 June 2018

Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

2 September 2018

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

3 December 2018

Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2752681

3 December 2018

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV disease progression in Australia in the time of combination antiretroviral therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rates of combination antiretroviral treatment change in Australia, 1997-2000

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19408354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAI.0B013E31819906D3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37364321&oldid=2175385185"